A Phase I Study of the Safety, Reactogenicity and Immunogenicity of Two Quadrivalent Seasonal Influenza Vaccines (fluzone® or Flublok®) with or Without One of Two Adjuvants (AF03 or Advax-CpG55.2) in Healthy Adults 18-45 Years of Age. Theresa E Hegmann,Emmanuel B Walter,Michael J Smith, James Campbell,Hana M El Sahly,Jennifer A Whitaker,C Buddy Creech,Irina V Ustyugova,Ana P Goncalvez,Aseem Pandey, Timothy Alefantis,Saranya Sridhar,Yoshikazu Honda-Okubo,Nikolai Petrovsky,Sharon E Frey,Getahun Abate,Grant Paulsen,Evan J Anderson,Christina A Rostad,Nadine Rouphael,Mamodikoe Makhene,Paul C Roberts,Bonifride Tuyishimire, Christopher Bryant, Patricia WinokurVaccine（2025）引用 0|浏览4AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
